Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Revenue

Tuoxin Pharmaceutical Group had revenue of 92.50M CNY in the quarter ending March 31, 2026, a decrease of -4.63%. This brings the company's revenue in the last twelve months to 373.85M, down -8.90% year-over-year. In the year 2025, Tuoxin Pharmaceutical Group had annual revenue of 378.34M, down -10.28%.

• Revenue (ttm): 373.85M
• Revenue Growth: -8.90%
• P/S Ratio: 8.98
• Revenue / Employee: 242.29K
• Employees: 1,543
• Market Cap: 3.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	378.34M	-43.35M	-10.28%
Dec 31, 2024	421.69M	-413.82M	-49.53%
Dec 31, 2023	835.51M	50.79M	6.47%
Jan 1, 2023	784.72M	282.24M	56.17%
Jan 1, 2022	502.48M	-25.46M	-4.82%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error